Shingles Vaccination: It’s Time to Tame the Beast Lurking Within
Expires: 11/30/2023 (subject to change)
- CE for this activity will not be available after this date.
Herpes zoster, more commonly referred to as shingles, is caused by the varicella zoster virus (VZV). Infection with VZV in early childhood is associated with the development of chickenpox, which causes a short-lived itchy rash and blisters. Although the virus enters a dormant latent stage after initial symptoms, VZV infection is lifelong, and reactivation at any point following primary infection may be associated with the development of shingles. Despite the evidence for the benefit associated with the shingles vaccine, vaccination rates remain suboptimal, and the incidence of shingles continues to rise. Nurse practitioners (NPs) are well-positioned to improve shingles vaccination rates. This monograph activity contains text, infographics, tables, and case studies to review shingles burden of disease and the importance of vaccination.
- Summarize the CDC recommendations regarding shingles vaccination in US adults.
- Identify candidates for shingles vaccination.
- Summarize RZV trial outcomes and safety data.
- Discuss the prevalence and disease burden of shingles.
- Explain the barriers that may be encountered surrounding shingles vaccination.
- Summarize effective communication techniques to utilize when addressing barriers to vaccination.
Ruth Carrico PhD, DNP, APRN, CIC, FSHEA, FNAP, FAANAudrey Stevenson PhD, MPH, MSN, FNP-BC
This program was planned in accordance with AANP CE Standards and Policies.
The activity faculty have the following disclosures:
All Planners involved in this activity have no relevant financial relationships to disclose. This educational activity is supported by an educational grant from GlaxoSmithKline.
- Ruth Carrico: Moderna and Novavax Advisory Boards for the topic of Covid-19, Pfizer Speakers Bureau, Advisory Board and Research for the topic of pneumonia, Sanofi Pasteur Speakers Bureau and Research for the topics of influenza and yellow fever
- Audrey Stevenson:
- Sanofi Pasteur: advisory Board, speakers Bureau influenza, meningococcal
- GSK: Advisory Board, meningococcal
- Pfizer: Speaker’s Bureau, meningococcal
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content:
- Monograph Presentations: Click the Play button to get access to the downloadable PDF monograph of the activity. Learners will be required to read all presented material in the PDF.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the affidavit confirming that you've reviewed all required content for the activity.
- Complete the post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.
For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
|1.5 Contact Hour(s) of CE,
0.75 of which may be applied towards Pharmacology